GlassScriptPhysician profile
Joe E Johnson Jr
NPI 1033191739
$3,311.87
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,119 · 2020: $1,307 · 2021: $886.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,281.37 | 2019-2021 | |
| Glaxosmithkline, LLC. | $651.12 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $464.98 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $290.84 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $226.90 | 2019-2021 | |
| Genentech USA, INC. | $99.99 | 2019 | |
| Lilly USA, LLC | $88.75 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $62.41 | 2019-2021 | |
| Medtronic, INC. | $57.22 | 2021 | |
| Genzyme Corporation | $31.55 | 2019 | |
| Mylan Specialty L.P. | $22.40 | 2020 | |
| Esperion Therapeutics, INC. | $18.78 | 2020 | |
| Circassia INC. | $15.56 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joe Johnson Jr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.